Oxcitas
Machine-learning platforms that predict and measure biological-age changes for clinical developers and clinics
Highlights
- New on EvolcAdded 2026-11-14
About Oxcitas
Oxcitas develops digital platforms combining machine learning, artificial intelligence and systems biology to assess, quantify and predict changes in biological age in response to treatment interventions. Its platforms combine disease signatures spanning genotypic, phenotypic and metabolic data.
The tools support patient stratification and clinical development, as well as use in clinics. Clinical focus areas include pulmonary, metabolic and cardiovascular disease, and central nervous system disorders; the company also offers tailored development for partners and clients.
Oxcitas was founded in 2017 and is headquartered in Cambridge, United Kingdom. It has advertised an open Founding Commercial Lead role.
Product: DISCOVER-oRx and PREDICT-oRx digital platforms for measuring and predicting biological-age changes associated with treatment interventions.
Jobs at Oxcitas
Leadership
- Bipin Patel · CEOSource: company website
More biotech & pharma companies
Oxford Medical Products
Develops gastroretentive hydrogel technologies for weight management and drug delivery applicationsNew on Evolcoxfordglobal.co.uk
Life-science conferences, expert webinars and editorial interviews connecting R&D leaders across pharma, biotech and academiaOxilio
Repurposes and reformulates existing drugs to develop cancer treatments for patients with unmet needsNew on EvolcOxsonics
Clinical-stage drug delivery company developing SonoTran, an ultrasound platform that boosts anti-cancer drug penetration into solid tumoursPangea Botanica
Develops TrkB-activating drug candidates for central nervous system disordersNew on EvolcParticology
Contract particle science and solid form services for pharma teams taking small-molecule drugs to formulated productsYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.